The CDK1/TFCP2L1/ID2 cascade offers a novel combination therapy strategy in a preclinical model of bladder cancer.

导出 OA

翻译打印收藏纠错

作者： Jinbeom,Heo ^[1] ; Jinyoung,Lee ^[2] ; Yun Ji,Nam ^[1] ; YongHwan,Kim ^[1] ; HongDuck,Yun ^[2] ; Seungun,Lee ^[1] ; Hyein,Ju ^[2] ; Chae-Min,Ryu ^[1] ; Seon Min,Jeong ^[2] ; Jinwon,Lee ^[1] ; Jisun,Lim ^[2] ; Yong Mee,Cho ^[1] ; Eui Man,Jeong ^[2] ; Bumsik,Hong ^[1] ; Jaekyoung,Son ^[3] ; Dong-Myung,Shin ^[4]

作者单位： Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[1] Department of Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[2] Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[3] Center for Cell Therapy, Asan Medical Center, Seoul, Korea. ^[4] Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. ^[5] Department of Pharmacy, College of Pharmacy, Jeju National University, Jeju, Korea. ^[6] Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Bio-Health Materials Core-Facility Center and Practical Translational Research Center, Jeju National University, Jeju, Korea. ^[7] Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. bshong@amc.seoul.kr. ^[8] Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. jaekson@amc.seoul.kr. ^[9] Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. d0shin03@amc.seoul.kr. ^[10] Department of Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. d0shin03@amc.seoul.kr. ^[11] Center for Cell Therapy, Asan Medical Center, Seoul, Korea. d0shin03@amc.seoul.kr. ^[12]